Fewer dollars, more sense.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Oncology

• Publication date

  2008-11-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2008.17.9564PMID 18854564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thyroid hormone induces hypoxia-inducible factor 1alpha gene expression through thyroid hormone receptor beta/retinoid x receptor alpha-dependent activation of hepatic leukemia factor.

  2008cited by this paper
• Bevacizumab plus irinotecan in recurrent glioblastoma.

  2008cited by this paper
• Bevacizumab for recurrent malignant gliomas

  2008cited by this paper
• Genetic pathways to primary and secondary glioblastoma.

  2007cited by this paper
• Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.

  2007cited by this paper
• Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.

  2007cited by this paper
• Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.

  2007cited by this paper
• Integrin inhibitors reaching the clinic.

  2007cited by this paper
• Insulin-like growth factor type I biology and targeting in malignant gliomas.

  2007cited by this paper
• AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

  2007cited by this paper
• Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells.

  2006cited by this paper
• Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion

  2006cited by this paper
• Cell-surface receptor for thyroid hormone and tumor cell proliferation

  2006cited by this paper
• Disparate effects of thyroid hormone on actions of epidermal growth factor and transforming growth factor-alpha are mediated by 3',5'-cyclic adenosine 5'-monophosphate-dependent protein kinase II.

  2004cited by this paper
• Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.

  2003cited by this paper
• Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.

  2002cited by this paper
• Insulin and Insulin-like Growth Factor-I Induce Vascular Endothelial Growth Factor mRNA Expression via Different Signaling Pathways*

  2000cited by this paper
• Thyroxine Promotes Association of Mitogen-activated Protein Kinase and Nuclear Thyroid Hormone Receptor (TR) and Causes Serine Phosphorylation of TR*

  2000cited by this paper

• Central nervous system

  2017cites this paper
• Documentation of thyroid function in clinical studies with sunitinib: why does it matter?

  2008cites this paper